NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,647 | -78.0% | 477,240 | -46.9% | 0.00% | – |
| Q2 2023 | $2,326,163 | -33.4% | 898,132 | +4.9% | 0.00% | – |
| Q1 2023 | $3,493,740 | +5.1% | 856,309 | +29.3% | 0.00% | – |
| Q4 2022 | $3,323,406 | -53.6% | 662,033 | +21.0% | 0.00% | -100.0% |
| Q3 2022 | $7,155,000 | -5.6% | 547,059 | -7.5% | 0.00% | 0.0% |
| Q2 2022 | $7,579,000 | -14.4% | 591,224 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $8,855,000 | +70.1% | 580,704 | +97.5% | 0.00% | 0.0% |
| Q4 2021 | $5,206,000 | +73.5% | 293,967 | +105.9% | 0.00% | – |
| Q3 2021 | $3,000,000 | -8.8% | 142,748 | -14.4% | 0.00% | – |
| Q2 2021 | $3,289,000 | -53.4% | 166,775 | -31.2% | 0.00% | -100.0% |
| Q1 2021 | $7,052,000 | +10.7% | 242,570 | +15.4% | 0.00% | 0.0% |
| Q4 2020 | $6,371,000 | +161.6% | 210,283 | +37.4% | 0.00% | – |
| Q3 2020 | $2,435,000 | -33.5% | 153,049 | -17.5% | 0.00% | -100.0% |
| Q2 2020 | $3,662,000 | +10362.9% | 185,521 | +6326.1% | 0.00% | – |
| Q1 2020 | $35,000 | -95.9% | 2,887 | -93.7% | 0.00% | – |
| Q4 2019 | $846,000 | +181.1% | 45,751 | +110.6% | 0.00% | – |
| Q3 2019 | $301,000 | – | 21,722 | +86788.0% | 0.00% | – |
| Q2 2019 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |